Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity
作者
Alessio Cortellini,Edoardo Garbo,Giulia La Cava,Fabrizio Citarella,Valentina Santo,Leonardo Brunetti,David J. Pinato,Jarushka Naidoo,Matthew J. Loza,Carlo Genova,Scott Gettinger,So Yeon Kim,Ritujith Jayakrishnan,Talal El Zarif,Marco Russano,Federica Pecci,Alessandro Di Federico,Michele Montrone,Dwight H. Owen,Diego Signorelli
出处
期刊:Lung Cancer [Elsevier BV] 日期:2025-10-16卷期号:209: 108799-108799